Drug Information

Drug General Information
Drug ID
D05EPI
Former ID
DNC014192
Drug Name
Isosorbide-di-(4-nitrophenyl carbamate)
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530646]
Formula
C20H18N4O10
Canonical SMILES
CCCNC(=O)OC1COC2C1OCC2OC(=O)NCCC
InChI
1S/C14H24N2O6/c1-3-5-15-13(17)21-9-7-19-12-10(8-20-11(9)12)22-14(18)16-6-4-2/h9-12H,3-8H2,1-2H3,(H,15,17)(H,16,18)/t9-,10+,11-,12-/m1/s1
InChIKey
FHZOSQQIPPAAMJ-WRWGMCAJSA-N
PubChem Compound ID
46232723
Target and Pathway
Target(s) Acetylcholinesterase Target Info Inhibitor [530646]
KEGG Pathway Glycerophospholipid metabolism
Cholinergic synapse
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database ATF-2 transcription factor network
PathWhiz Pathway Phospholipid Biosynthesis
WikiPathways Monoamine Transport
Biogenic Amine Synthesis
Acetylcholine Synthesis
Integrated Pancreatic Cancer Pathway
References
Ref 530646Bioorg Med Chem. 2010 Feb;18(3):1045-53. Epub 2010 Jan 6.Isosorbide-based cholinesterase inhibitors; replacement of 5-ester groups leading to increased stability.
Ref 530646Bioorg Med Chem. 2010 Feb;18(3):1045-53. Epub 2010 Jan 6.Isosorbide-based cholinesterase inhibitors; replacement of 5-ester groups leading to increased stability.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.